Literature DB >> 23683383

Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair.

Athanasios Saratzis1, Pantelis Sarafidis, Nikolaos Melas, Nikolaos Saratzis, George Kitas.   

Abstract

BACKGROUND: Renal function may be associated with poor outcome following endovascular abdominal aortic aneurysm repair (EVAR), but this relationship has not been adequately investigated. The aim of this study is to evaluate the association of estimated glomerular filtration rate (eGFR) with cardiovascular events and all-cause mortality after EVAR.
METHODS: Prospective cohort study of patients undergoing elective EVAR; eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration formula, and patients were divided in four groups (eGFR ≥ 90 mL/min/1.73 m(2), group 1; 60-89, group 2; 30-59, group 3; <30, group 4). Composite end point consisted of death, nonfatal myocardial infarction, stroke, and vascular complications. Kaplan-Meier curves were constructed, and between-group comparisons were performed adjusted for variables that differed at baseline.
RESULTS: A total of 383 patients (mean age, 69 ± 8 years; mean abdominal aortic aneurysm diameter, 6.2 ± 1.4 cm) were included. Over a mean follow-up of 34 ± 12 months, the following events occurred: 20 deaths (5.2%), 15 nonfatal myocardial infarctions (3.9%), 9 nonfatal strokes (2.3%), and 7 peripheral vascular complications (1.8%). Patients with an eGFR <30 had the highest mortality (35%) and incidence of complications (80%) as per the end point (P = .009 and P < .001, respectively). Adjusted Cox-regression analysis showed that a higher eGFR at baseline by 1 mL/min/1.73 m(2) was associated with a 5% lower likelihood of complications as per the end point (P < .001; hazard ratio, 0.95; 95% confidence interval, 0.94-0.97) and a 6% lower likelihood of death (P < .001; hazard ratio, 0.94; 95% confidence interval, 0.92-0.97).
CONCLUSIONS: Impaired renal function is associated with an increase in cardiovascular events and mortality following elective EVAR.
Copyright © 2013 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23683383     DOI: 10.1016/j.jvs.2013.03.036

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Renal dysfunction after endovascular abdominal aortic aneurysm repair: time to use the correct outcome measures.

Authors:  Athanasios N Saratzis; Pantelis A Sarafidis
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

Review 2.  Osteoprotegerin and kidney disease.

Authors:  Alejandra Montañez-Barragán; Isaias Gómez-Barrera; Maria D Sanchez-Niño; Alvaro C Ucero; Liliana González-Espinoza; Alberto Ortiz
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

3.  Long-Term Renal Function after Endovascular Aneurysm Repair.

Authors:  Athanasios Saratzis; Michael F Bath; Seamus Harrison; Robert D Sayers; Asif Mahmood; Pantelis Sarafidis; Matthew J Bown
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-20       Impact factor: 8.237

4.  Targets to prevent prolonged length of stay after endovascular aortic repair.

Authors:  J Hunter Mehaffey; Damien J LaPar; Margret C Tracci; Kenneth J Cherry; John A Kern; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2015-09-12       Impact factor: 4.268

Review 5.  [Complications following aortic reconstruction surgery].

Authors:  E Kleinspehn; F Heidemann; C A Behrendt; T Kölbel; E S Debus
Journal:  Chirurg       Date:  2015-07       Impact factor: 0.955

6.  A perioperative strategy for abdominal aortic aneurysm in patients with chronic renal insufficiency.

Authors:  Makoto Haga; Katsuyuki Hoshina; Kunihiro Shigematsu; Toshiaki Watanabe
Journal:  Surg Today       Date:  2015-12-08       Impact factor: 2.549

7.  Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years.

Authors:  J T Powell; M J Sweeting; P Ulug; J D Blankensteijn; F A Lederle; J-P Becquemin; R M Greenhalgh
Journal:  Br J Surg       Date:  2017-02       Impact factor: 6.939

8.  What factors counteract mid-term survival following endovascular repair of abdominal aortic aneurysms?

Authors:  Ertekin Utku Ünal; Hakkı Zafer İscan; Bekir Bogachan Akkaya; İsa Civelek; Mehmet Karahan; Ece Celikten; Göktan Askin; Hayrettin Levent Mavioğlu; Mehmet Ali Özatik
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-05-15

9.  Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Pantelis Sarafidis; Sven Martens; Athanasios Saratzis; Daniella Kadian-Dodov; Patrick T Murray; Catherine M Shanahan; Allen D Hamdan; Daniel T Engelman; Ulf Teichgräber; Charles A Herzog; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Holger Reinecke; Kirsten Johansen
Journal:  Cardiovasc Res       Date:  2022-09-20       Impact factor: 13.081

10.  Outcomes of Endovascular Repair for Abdominal Aortic Aneurysms: A Nationwide Survey in Japan.

Authors:  Katsuyuki Hoshina; Shin Ishimaru; Yusuke Sasabuchi; Hideo Yasunaga; Kimihiro Komori
Journal:  Ann Surg       Date:  2019-03       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.